Owais Abdelhfeez Scoops First Prize of My Project on its 5th Season
Owais Mohammed Abdelhfeez Hassan, a student at the University of Medical Science and Technology, won the first prize of “My Project for the Fifth Season” to receive a 300,000 Sudanese Pounds prize money and a training trip to Britain.
Owais is enrolled in the in the Global MBA Impact in Entrepreneurship provided by the Italian University Cattolica in partnership with the University of Medical Sciences and Technology.
Owais has previously worked for several years with a number of companies operating in the field of Communications Engineering. Currently, he owns a wooden products company and works on a irrigation system. His project “DOUASH” is aiming at solving the problem of irrigation in medium-sized agricultural farms to increase the material return of farmers.The project strives to provide irrigation water by employing well-planned irrigation devises, responding to the specific needs of each plant. In this sense “DOUASH” is project for producing high quality national product at a competitive price.Owais maintains that he “believes that each of us has a role to play in this life.
It is our duty to society to contribute our vision and vision to the development and reconstruction of our societies so that future generations can enjoy a dignified livelihood for future generations and ensure the continuity of life”. He reiterates his belief that change comes with production and pushing the wheel of development forward, and not through theorizing and contaminating ideas with talk about economic theories.
Owais is the third student at UMST to win the “My Project” award for creative initiatives and new non-traditional inventions.
Declaration by the High Representative on behalf of the European Union on the situation in Sudan:
The EU is closely following the situation in Sudan. Measures being adopted under the newly declared state of emergency, the increased role of the military in governing the country, further curtail fundamental freedoms and undermine the recent offer of a new political dialogue.
They create a permissive climate for the security services to act with impunity against peaceful protesters. The latest attacks against unarmed students in the University of Medical Sciences and Technology and against peaceful protesters in Omdurman, are deeply disturbing.
Genuine political dialogue requires an environment in which the Sudanese people can exercise their legitimate right to express their views. This will be essential to create the national consensus needed to find sustainable responses to Sudan’s deep political and economic crisis.
The EU expects the Sudanese government to release all the journalists, members of the opposition, human rights defenders and other protesters in detention. Some of those with whom the dialogue is set to take place have been arbitrarily detained for over two months now. An independent investigation into the deaths and abuses should be undertaken with those responsible held to account.
The respect for these fundamental principles are at the core of the EU’s phased engagement with the government of Sudan. We will continue to monitor the situation and review the impact of the Government of Sudan’s actions on ites relations with the European Union.
* This statement was issued by Ms Frederica Mogherini, the EU High Representative of the Union for Foreign Affairs and Security Policy and Vice President of the European Commission in agreement with the European Union’s member states.
The European Union consists of 28 European countries (Austria, Belgium, Bulgaria, Croatia, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Netherlands, Poland, Portugal, Romania, Slovakia, Slovenia, Spain, Sweden and the United Kingdom).
A delegation of the National Commission of Nigerian Universities will visit on Tuesday the 15th the University to hold a meeting with the top management at the GCC (Global Conference Center).
The purpose of the visit is to be fully informed of the experiences of the Sudanese medical educational institutions and professional establishments working in the field. The delegation will also investigate areas of future cooperation between the University of Medical Sciences and technology and Nigerian Universities.[wonderplugin_slider id=75]
Dr Iman Tag Elsir Abdullah
• PhD in Chemistry of Natural Products.
• Assistant Professor at the University of Medical Sciences and Technology.
• Head of Chemistry Department, UMST.
• Scientific Consultant, Sudanese Union of Herbalists and Complementary Medicine.
• Member of the Committee of the Association of Complementary Medicine, Medical and Health Professions.
• Director of Taj Al Thuraya Center for Treatment of Asthma.
Dr Iman is a proud holder of :
International and national patent of international intellectual property WIPO (pct) Geneva
This entails the protection and registration of the product in Sudan, South America, South Africa, India UAE, Saudi Arabia and Egypt.
An international searching report emphasized that the product is a new invention and can be manufactured in accordance with the patent’s conditions and within the period circulation as specified by the global trading of WIPO;
- Missions and Representation:
Sudan representative of Intellectual Property at the Conference of Women Inventors and Innovators in the Middle East (International Intellectual Property Organization in association with the League of Arab States (Cairo).
- Scientific Inimitability Conference for Medical Sciences (Abu Dhabi).
- Interview in the program Good Morning Arabs, Arabiya Channel, Dubai.
- Numerous ppublications of scientific papers.
- National Symposium on Patent Cooperation Treaty (PCT) regarding worldwide Patent Awarding System (Ministry of Justice in Cooperation with the Africa International University).
- Launching of experiments in 2011 at the National Research Center and then depositing the patent papers (action plan) with the Intellectual Property of Sudan at the General Registrar of Intellectual Property. In 2013 Papers were later transferred to the National Council of Medicines and Toxins. Following sending all the relevant results a patent was issued testifying that the product is safe and can be used as a treatment and subsequently:
• The outcome was published globally in September 2016.
• Its use has proved to be beneficial for many of its users.
• The product is composed of herbal and natural products and honey. It does not have any additives or industrial components.